Jobs report, SpaceX and Eli Lilly earnings headline week of data and results

InstantWhy

The numbers

Yahoo Finance reports that investors face a busy week of economic data and corporate earnings, with the monthly jobs report due alongside results from SpaceX, AMD, Eli Lilly and Palantir. The calendar combines labor market data with earnings from both public technology companies and private aerospace firms. The confluence of macro data and tech results arrives as markets continue to weigh the strength of the economy and the pace of spending on artificial intelligence infrastructure.

Why it matters

SpaceX results offer a rare window into private aerospace economics, while AMD and Palantir earnings will test whether AI infrastructure spending is holding up after recent questions about returns on that investment. Eli Lilly's results matter because weight-loss drug sales have become a significant driver of both the stock and broader healthcare sector performance.

How this compares

Palantir shares jumped after hours on August 3 following a second-quarter earnings beat, according to our prior coverage. Dow futures opened the week of August 2 with investors bracing for the same slate of earnings, alongside easing tensions with Iran that had briefly lifted oil prices. The combination of labor data and tech earnings has become a recurring test for markets trying to reconcile economic resilience with the sustainability of AI capital expenditure.

What to watch

The jobs report will either reinforce or challenge the narrative of a cooling but stable labor market that has kept the Fed on hold. Earnings from the technology and pharmaceutical companies will clarify whether two of the market's strongest themes—AI infrastructure build-out and weight-loss drug adoption—are accelerating or facing headwinds.

InstantWhy

HSBC shares rise after pretax profit beats estimates on higher interest income

The bank's quarterly results topped analyst forecasts as net interest income and fee revenue climbed

HSBC 2026-08-04 05:06

InstantWhy

Sumitomo Pharma shares targeted by short seller over revenue accounting claims

Gotham City Research alleges the Japanese drugmaker has misstated sales figures, though the company has not ye

Sumitomo Pharma 4506.T 2026-08-04 03:43

InstantWhy

Microsoft cloud revenue growth prompts fresh valuation debate

The software giant's Azure business continues to post strong growth, raising questions about whether recent ga

BREAKING MSFT 2026-08-04 03:08